2Freedland SJ,Moul JW.Prostate specific antigen recurrence after definitive therapy [J].J Urol,2007,177(6):1985-1991.
3Simsir A,Cal C,Mammadov R,et al.Biochemical recurrence after radical prostatectomy:is the disease or the surgeon to blame[J].Int Braz J Urol,2011,37(3):328-334.
4Stephenson AJ,Kattan MW,Eastham JA,et al.Defining biochemical recurrence of prostate cancer after radical prostatectomy:a proposal for a standardized definition [J]. J Clin Oncol,2006,24(24):3973-3978.
5Hattab EM,Koch MO,Eble JN,et al.Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason scores 7 prostatic adenocarcinoma[J].J Urol,2006,175(5):1695-1699.
6Amling CL,Bergstralh EJ,Blute ML,et al.Defining prostate specific antigen progression after radical prostatectomy:what is the most appropriate cut point[J] ? J Urol,2001,165:1146-1151.
7Warner JN,Nunez RN,Mmeje CO,et al.Impact of margin status at 37 months after robot assisted radical prostatectomy[J].Can J Urol,2011,18(6):6043-6049.
8Swanson GP,Basler JW.Prognostic factors for failure after prostatectomy [J].J Cancer,2010,7(2):1-19.
9Alenda O,Plpussard G,Mouracade P,et al.Impact of the primary Gleason pattern on biochemical recurrence-free survival after radical prostatectomy:a single-center cohort of 1248 patients with Gleason 7 tumors[J].World J Urol,2011,29(5):671-676.
10Barry Delongchampps N,Peyromaure M,Kaptcha F,et al.pT3N0 prostate cancer treated with radical prostatectomy as sole treatment:Oncological results and predictive factors ofrecurrence[J].Prog Urol,2012,22(2):100-105.
